Daniel J. Cox, PhD
Daniel J. Cox, PhD, a professor of psychiatric and internal medicine in the Department of Psychiatry and Neurobehavioral Sciences, was awarded a $3.5 million R01 grant from the NIH for a multi-center study of adults with newly diagnosed type 2 diabetes (T2D). In the study, 200 adults with newly diagnosed T2D will be randomized into two groups: one group will receive routine care by their primary care provider and the other group will additionally receive a lifestyle intervention- Glycemic Excursion Minimization (GEM). GEM does not involve weight loss, but instead focuses on reducing glucose excursion by food and activity choices. GEM participants receive a training manual, text messages, continuous glucose monitoring supplies and a FitBit.
Participants will be assessed before treatment, and three months and 12 months post-treatment, and their diabetes expenditures will be tracked. The goal is to see whether GEM can put diabetes in remission, while reducing medical costs. Watch a VuMedi presentation of GEM’s background and treatment.